Erzsébet Rásó

Research Profile

Living Beings

Disorders

Anatomy

Procedures

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Tibor Fekete; Erzsébet Rásó; Imre Pete; Bálint Tegze; István Liko; Gyöngyi Munkácsy; Norbert Sipos; János Rigó; Balázs Györffy
Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples.
András Telekes; Erzsébet Rásó; Károly Vékey
[Investigation of fatty acid profile for diagnostic purposes in mouse melanoma].
Zita Hegedûs; Tamás Barbai; Péter Tátrai; Balázs Hegedûs; András Kiss; Erzsébet Rásó; György Bodoky
[Effect of KRAS mutation status on the efficiency of Avastin therapy of colorectal cancer].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Erzsébet Rásó (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Tibor Fekete; Erzsébet Rásó; Imre Pete; Bálint Tegze; István Liko; Gyöngyi Munkácsy; Norbert Sipos; János Rigó; Balázs Györffy
Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples.
International journal of cancer. Journal international du cancer 2012;131(1):95-105.
2011: András Telekes; Erzsébet Rásó; Károly Vékey
[Investigation of fatty acid profile for diagnostic purposes in mouse melanoma].
Magyar onkologia 2011;55(3):199-204.
2011: Zita Hegedûs; Tamás Barbai; Péter Tátrai; Balázs Hegedûs; András Kiss; Erzsébet Rásó; György Bodoky
[Effect of KRAS mutation status on the efficiency of Avastin therapy of colorectal cancer].
Magyar onkologia 2011;55(2):99-100, 102-4.
2010: József Tímár; Balázs Hegedüs; Erzsébet Rásó
KRAS mutation testing of colorectal cancer for anti-EGFR therapy: dogmas versus evidence.
Current cancer drug targets 2010;10(8):813-23.
2010: József Tímár; Balázs Gyorffy; Erzsébet Rásó
Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?
Clinical & experimental metastasis 2010;27(6):371-87.
2010: László G Puskás; Liliána Z Fehér; Csaba Vizler; Ferhan Ayaydin; Erzsébet Rásó; Eszter Molnár; István Magyary; Iván Kanizsai; Márió Gyuris; Ramóna Madácsi; et al.
Polyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cells.
Lipids in health and disease 2010;9():56.
2008: József Lövey; Bíborka Bereczky; Réka Gilly; István Kenessey; Erzsébet Rásó; Erika Simon; Judit Dobos; Agnes Vágó; Miklós Kásler; Balázs Döme; et al.
Recombinant human erythropoietin alpha improves the efficacy of radiotherapy of a human tumor xenograft, affecting tumor cells and microvessels.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(1):1-7.
2007: Tamás Deli; Norbert Varga; Attila Adám; István Kenessey; Erzsébet Rásó; László G Puskás; József Tóvári; János Fodor; Mónika Fehér; Gyula P Szigeti; et al.
Functional genomics of calcium channels in human melanoma cells.
International journal of cancer. Journal international du cancer 2007;121(1):55-65.
2007: Gayane Badalian; Tamás Barbai; Erzsébet Rásó; Katalin Derecskei; Miklós Szendrôi; József Tímár
Phenotype of bone metastases of non-small cell lung cancer: epidermal growth factor receptor expression and K-RAS mutational status.
Pathology oncology research : POR 2007;13(2):99-104.
2007: József Lövey; István Kenessey; Erzsébet Rásó; Judit Dobos; Agnes Vágó; Miklós Kásler; Krisztina Futosi; Balázs Döme; József Tímár; József Tóvári
[Human recombinant erythropoietin-alpha increases the efficacy of irradiation in preclinical model].
Magyar onkologia 2007;51(1):53-61.
2007: J Lukits; E Remenár; E Rásó; A Ladányi; M Kásler; J Tímár
Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer.
International journal of oncology 2007;30(1):155-60.
2006: J Tímár; L Mészáros; A Ladányi; L G Puskás; E Rásó
Melanoma genomics reveals signatures of sensitivity to bio- and targeted therapies.
Cellular immunology 2006;244(2):154-7.
2005: József Tóvári; Réka Gilly; Erzsébet Rásó; Sándor Paku; Bíborka Bereczky; Norbert Varga; Agnes Vágó; József Tímár
Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models.
Cancer research 2005;65(16):7186-93.
2005: Balázs Döme; Erzsébet Rásó; Judit Dobos; Livia Mészáros; Norbert Varga; László G Puskás; Liliána Z Fehér; László Z Fehér; Tamár Lörincz; Andrea Ladányi; et al.
Parallel expression of alphaIIbbeta3 and alphavbeta3 integrins in human melanoma cells upregulates bFGF expression and promotes their angiogenic phenotype.
International journal of cancer. Journal international du cancer 2005;116(1):27-35.
2005: J Timár; L Mészáros; Z Orosz; A Albini; E Rásó
WT1 expression in angiogenic tumours of the skin.
Histopathology 2005;47(1):67-73.
2005: Erzsébet Rásó; József Tóvári; Andrea Ladányi; Norbert Varga; József Tímár
Ligand-mimetic anti-alphaIIb beta3 antibody PAC-1 inhibits tyrosine signaling, proliferation and lung colonization of melanoma cells.
Pathology oncology research : POR 2005;11(4):218-23.
2005: József Tímár; József Tóvári; Erzsébet Rásó; Livia Mészáros; Bíborka Bereczky; Károly Lapis
Platelet-mimicry of cancer cells: epiphenomenon with clinical significance.
Oncology 2005;69(3):185-201.
2005: Bíborka Bereczky; Réka Gilly; Erzsébet Rásó; Agnes Vágó; József Tímár; József Tóvári
Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest.
Clinical & experimental metastasis 2005;22(1):69-76.
2004: C Forster-Horváth; L Mészáros; E Rásó; B Döme; A Ladányi; M Morini; A Albini; J Tímár
Expression of CD44v3 protein in human endothelial cells in vitro and in tumoral microvessels in vivo.
Microvascular research 2004;68(2):110-8.
2004: Erzsébet Rásó; Balázs Döme; Beáta Somlai; Alex Zacharek; Wolfgang Hagmann; Kenneth V Honn; József Tímár
Molecular identification, localization and function of platelet-type 12-lipoxygenase in human melanoma progression, under experimental and clinical conditions.
Melanoma research 2004;14(4):245-50.
2004: Erzsébet Rásó; Lívia Mészáros; Adriana Albini; József Tímár
A WT1 expressing metastatic human Kaposi sarcoma xenograft model.
Pathology oncology research : POR 2004;10(1):22-5.
2003: Erzsébet Rásó; Sándor Paku; László Kopper; József Tímár
Trace elements improve survival of DTIC-treated mice with overt liver metastases of Lewis lung carcinoma.
Pathology oncology research : POR 2003;9(2):96-9.
2003: E Magyarosy; N Varga; J Timár; E Rásó
Follow-up of minimal residual disease in acute childhood lymphoblastic leukemia by WT1 gene expression in the peripheral blood: the Hungarian experience.
Pediatric hematology and oncology 2003;20(1):65-74.
2002: K Fazekas; E Rásó; M Zarándi; J Dudás; J Tímár
Basic HGF-like peptides inhibit generation of liver metastases in murine and human tumor models.
Anticancer research 2002;22(5):2575-9.
2002: J Tímár; E Rásó; B Döme; A Ladányi; T Bánfalvi; K Gilde; A Raz
Expression and function of the AMF receptor by human melanoma in experimental and clinical systems.
Clinical & experimental metastasis 2002;19(3):225-32.
2001: A Zalatnai; K Lapis; B Szende; E Rásó; A Telekes; Resetár A; M Hidvégi
Wheat germ extract inhibits experimental colon carcinogenesis in F-344 rats.
Carcinogenesis 2001;22(10):1649-52.
2001: E Rásó; J Tóvári; K Tóth; S Paku; M Trikha; K V Honn; J Tímár
Ectopic alphaIIbbeta3 integrin signaling involves 12-lipoxygenase- and PKC-mediated serine phosphorylation events in melanoma cells.
Thrombosis and haemostasis 2001;85(6):1037-42.
2001: C Forster-Horváth; J Bocsi; E Rásó; T I Orbán; E Olah; J Tímár; A Ladányi
Constitutive intracellular expression and activation-induced cell surface up-regulation of CD44v3 in human T lymphocytes.
European journal of immunology 2001;31(2):600-8.
2000: J Timár; E Rásó; B Döme; L Li; D Grignon; D Nie; K V Honn; W Hagmann
Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential.
International journal of cancer. Journal international du cancer 2000;87(1):37-43.
2000: K Fazekas; O Csuka; I Köves; E Rásó; J Tímár
Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis.
Clinical & experimental metastasis 2000;18(8):639-49.
1999: M Hidvégi; E Rásó; R Tömösközi-Farkas; B Szende; S Paku; L Prónai; J Bocsi; K Lapis
MSC, a new benzoquinone-containing natural product with antimetastatic effect.
Cancer biotherapy & radiopharmaceuticals 1999;14(4):277-89.
1999: M Hidvégi; E Rásó; R Tömösközi Farkas; K Lapis; B Szende
Effect of MSC on the immune response of mice.
Immunopharmacology 1999;41(3):183-6.
1999: J Timár; E Rásó; K V Honn; W Hagmann
12-lipoxygenase expression in human melanoma cell lines.
Advances in experimental medicine and biology 1999;469():617-22.
1998: B Szende; E Rásó; M Hidvégi; F R Tömösköziné; S Paku; L Prónai; J Bocsi; K Lapis
[A new benzoquinone-containing antimetastatic product].
Orvosi hetilap 1998;139(48):2893-7.
1997: J Tóvári; S Paku; E Rásó; G Pogány; I Kovalszky; A Ladányi; K Lapis; J Tímár
Role of sinusoidal heparan sulfate proteoglycan in liver metastasis formation.
International journal of cancer. Journal international du cancer 1997;71(5):825-31.
1996: E Rásó; J Tímár; K Lapis
Inhibition of the progression of human and rat Wilms' tumor by Tiazofurin.
Anticancer research 1996;16(6A):3333-9.
1996: K Y Lapis; J Bocsi; J Tóvári; I Bartha; J Timár; E Rásó
Antiinvasive effects of Tiazofurin on liver-metastatic human colon carcinoma xenografts.
Anticancer research 1996;16(6A):3323-31.
1996: J Tímár; E Rásó; Z S Fazakas; S Silletti; A Raz; K V Honn
Multiple use of a signal transduction pathway in tumor cell invasion.
Anticancer research 1996;16(6A):3299-306.
1995: J Tímár; C Diczházi; I Bartha; G Pogány; S Paku; E Rásó; J Tóvári; A Ladányi; K Lapis; L Kopper
Modulation of heparan-sulphate/chondroitin-sulphate ratio by glycosaminoglycan biosynthesis inhibitors affects liver metastatic potential of tumor cells.
International journal of cancer. Journal international du cancer 1995;62(6):755-61.
1995: A Jeney; I Kovalszky; E Rásó; R E Durand; J Fürész; K Lapis
The biological activity of cisplatin and dibromodulcitol in combination therapy.
British journal of cancer 1995;71(2):317-21.
1995: J Timár; C Diczházi; A Ladányi; E Rásó; W Hornebeck; L Robert; K Lapis
Interaction of tumour cells with elastin and the metastatic phenotype.
Ciba Foundation symposium 1995;192():321-35; discussion 335-7.
1994: E Rásó; J Timár; S Paku; K Lapis
Metastasizing rat nephroblastoma. A rodent Wilms' tumour model.
Carcinogenesis 1994;15(6):1243-9.